A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.
PHASE2CompletedINTERVENTIONAL
Enrollment
188
Participants
Timeline
Start Date
July 31, 1988
Study Completion Date
December 31, 1990
Conditions
EpilepsyEpilepsies, PartialSeizures
Interventions
DRUG
topiramate
All Listed Sponsors
lead
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
INDUSTRY
NCT00236691 - A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures. | Biotech Hunter | Biotech Hunter